Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments

In recent years, new treatments have been studied for relapsed-refractory multiple myeloma (RRMM), including two CAR-T products and a variety of non-CAR-T agents. Since direct comparisons between these innovative treatments are not available, indirect comparisons can be of interest. Reconstruction o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cancanelli, Luca, Rivano, Melania, Di Spazio, Lorenzo, Chiumente, Marco, Mengato, Daniele, Messori, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844331/
https://www.ncbi.nlm.nih.gov/pubmed/36648884
http://dx.doi.org/10.3390/hematolrep15010006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844331/
https://www.ncbi.nlm.nih.gov/pubmed/36648884
http://dx.doi.org/10.3390/hematolrep15010006

Ejemplares similares